CDH2 and breast cancer: As expected, when mRNA levels of these EMT markers were measured in our cells, we found significant decreased E-cadherin levels (Figure 5a,b), an epithelial marker, increased N-cadherin levels (Figure 5c,d), and a mesenchymal marker in both BC lines expressing the miR-155-T allele.